يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"Angiotensin receptor antagonists – therapeutic use"', وقت الاستعلام: 1.59s تنقيح النتائج
  1. 1

    المساهمون: Cardiology

    المصدر: BMJ Open, Vol 11, Iss 3 (2021)
    BMJ Open
    BMJ open, 11(3). BMJ Publishing Group

    وصف الملف: application/pdf

  2. 2

    المساهمون: Groningen Institute for Organ Transplantation (GIOT), Groningen Kidney Center (GKC), Cardiovascular Centre (CVC), Microbes in Health and Disease (MHD)

    المصدر: European Heart Journal, 41(19), 1810-1817. Oxford University Press
    European Heart Journal

    وصف الملف: application/pdf

  3. 3

    المصدر: European Journal of Internal Medicine, Vol. 25, No 2 (2014) pp. 173-176

  4. 4
  5. 5

    المساهمون: Neyses, Ludwig [collaborator], Packer, M, Mcmurray, J, Desai, A, Gong, J, Lefkowitz, M, Rizkala, A, Rouleau, J, Shi, V, Solomon, S, Swedberg, K, Zile, M, Andersen, K, Arango, J, Arnold, J, Belohlavek, J, Bohm, M, Boytsov, S, Burgess, L, Cabrera, W, Calvo, C, Chen, C, Dukat, A, Duarte, Y, Erglis, A, Fu, M, Gomez, E, Gonzalez-Medina, A, Hagege, A, Huang, J, Katova, T, Kiatchoosakun, S, Kim, K, Kozan, O, Llamas, E, Martinez, F, Merkely, B, Mendoza, I, Mosterd, A, Negrusz-Kawecka, M, Peuhkurinen, K, Ramires, F, Refsgaard, J, Rosenthal, A, Senni, M, Jr, A, Silva-Cardoso, J, Squire, I, Starling, R, Teerlink, J, Vanhaecke, J, Vinereanu, D, Wong, R

    المصدر: Circulation, 131, 54-61
    CIRCULATION
    r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
    instname
    Circulation, 131(1), 54-61. United States (2015).
    PARADIGM-HF Investigators and Coordinators 2015, ' Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure ', Circulation, vol. 131, no. 1, pp. 54-61 . https://doi.org/10.1161/CIRCULATIONAHA.114.013748
    Circulation, 131, 1, pp. 54-61

    مصطلحات موضوعية: Angiotensin receptor, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], receptors, Tetrazoles, heart failure, Angiotensin-Converting Enzyme Inhibitors, Kaplan-Meier Estimate, Sacubitril, Angiotensin, Heart failure, Neprilysin, Receptors, Aminobutyrates, Angiotensin Receptor Antagonists, Biomarkers, Double-Blind Method, Enalapril, Heart Failure, Humans, Natriuretic Peptide, Brain, Peptide Fragments, Risk Factors, Stroke Volume, Survivors, Treatment Outcome, Troponin, Disease Progression, Medicine (all), Cardiology and Cardiovascular Medicine, Physiology (medical), Enalapril/therapeutic use, Heart Failure/blood, Receptor, Systèmes cardiovasculaire & respiratoire [D03] [Sciences de la santé humaine], Troponin/blood, Angiotensin Receptor Antagonists/therapeutic use, Drug Combinations, Angiotensin-Converting Enzyme Inhibitors/therapeutic use, Tetrazoles/therapeutic use, Cardiology, Valsartan, Heart Failure/blood/drug therapy/physiopathology, medicine.drug, medicine.medical_specialty, neprilysin, receptors, angiotensin, Internal medicine, Renin–angiotensin system, medicine, heart failure, neprilysin, receptors, angiotensin, business.industry, Biphenyl Compounds, medicine.disease, Endocrinology, Aminobutyrates/therapeutic use, Stroke Volume/physiology, Natriuretic Peptide, Brain/blood, Cardiovascular & respiratory systems [D03] [Human health sciences], business, Neprilysin/antagonists & inhibitors, Peptide Fragments/blood, Sacubitril, Valsartan, Biomarkers/blood

    وصف الملف: STAMPA; application/pdf

  6. 6

    المساهمون: Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National de la Recherche Agronomique (INRA), De Bruyne, B, Fearon, Wf, Pijls, Nh, Barbato, Emanuele, Tonino, P, Piroth, Z, Jagic, N, Mobius Winckler, S, Rioufol, G, Witt, N, Kala, P, Maccarthy, P, Engstr?m, T, Oldroyd, K, Mavromatis, K, Manoharan, G, Verlee, P, Frobert, O, Curzen, N, Johnson, Jb, Limacher, A, N?esch, E, J?ni, P, Fame, 2 Trial Investigators, Cardiovascular Biomechanics

    المصدر: New England Journal of Medicine
    New England Journal of Medicine, Massachusetts Medical Society, 2014, 371 (13), pp.1208-17. ⟨10.1056/NEJMoa1408758⟩
    De Bruyne, Bernard; Fearon, William F; Pijls, Nico H J; Barbato, Emanuele; Tonino, Pim; Piroth, Zsolt; Jagic, Nikola; Mobius-Winckler, Sven; Riouffol, Gilles; Witt, Nils; Kala, Petr; MacCarthy, Philip; Engström, Thomas; Oldroyd, Keith; Mavromatis, Kreton; Manoharan, Ganesh; Verlee, Peter; Frobert, Ole; Curzen, Nick; Johnson, Jane B; ... (2014). Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease. New England journal of medicine NEJM, 371(13), pp. 1208-1217. Massachusetts Medical Society MMS 10.1056/NEJMoa1408758 <http://dx.doi.org/10.1056/NEJMoa1408758>
    FAME 2 Trial Investigators 2014, ' Fractional flow reserve-guided PCI for stable coronary artery disease ', New England Journal of Medicine, vol. 371, no. 13, pp. 1208-1217 . https://doi.org/10.1056/NEJMoa1408758
    The New England Journal of Medicine, 371(13), 1208-1217. Massachussetts Medical Society

    وصف الملف: application/pdf

  7. 7

    المساهمون: Bedrijfsbureau CD, RS: CARIM - R3 - Vascular biology

    المصدر: Kaschina, E, Lauer, D, Schmerler, P, Unger, T & Steckelings, U M 2014, ' AT2 Receptors Targeting Cardiac Protection Post-Myocardial Infarction ', Current Hypertension Reports, vol. 16, no. 7, 441 . https://doi.org/10.1007/s11906-014-0441-0
    Current Hypertension Reports, 16(7):441. Current Medicine Group

  8. 8

    المساهمون: Mcmurray, J, Packer, M, Desai, A, Gong, J, Greenlaw, N, Lefkowitz, M, Rizkala, A, Shi, V, Rouleau, J, Solomon, S, Swedberg, K, Zile, M, Andersen, K, Arango, J, Arnold, M, Belohlavek, J, Bohm, M, Boytsov, S, Burgess, L, Cabrera, W, Chen, C, Erglis, A, Fu, M, Gomez, E, Gonzalez, A, Hagege, A, Katova, T, Kiatchoosakun, S, Kim, K, Bayram, E, Martinez, F, Merkely, B, Mendoza, I, Mosterd, A, Negrusz-Kawecka, M, Peuhkurinen, K, Ramires, F, Refsgaard, J, Senni, M, Sibulo, A, Silva-Cardoso, J, Squire, I, Starling, R, Vinereanu, D, Teerlink, J, Wong, R

    المصدر: McMurray, J, Packer, M, Desai, A, Gong, J, Greenlaw, N, Lefkowitz, M, Rizkala, A, Shi, V, Rouleau, J, Solomon, S, Swedberg, K, Zile, M R, Andersen, K, Arango, J L, Arnold, M, Bĕlohlávek, J, Böhm, M, Boytsov, S, Burgess, L, Cabrera, W, Chen, C-H, Erglis, A, Fu, M, Gomez, E, Gonzalez, A, Hagege, A-A, Katova, T, Kiatchoosakun, S, Kim, K-S, Bayram, E, Martinez, F, Merkely, B, Mendoza, I, Mosterd, A, Negrusz-Kawecka, M, Peuhkurinen, K, Ramires, F, Refsgaard, J, Senni, M, Sibulo, A S, Silva-Cardoso, J, Squire, I, Starling, R C, Vinereanu, D, Teerlink, J R, Wong, R & PARADIGM-HF Committees and Investigators 2015, ' A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure ', European Heart Journal, vol. 36, no. 7, pp. 434-9 . https://doi.org/10.1093/eurheartj/ehu455
    European Heart Journal

    وصف الملف: application/pdf; STAMPA

  9. 9